mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.1 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.1 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |